| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 3 | |
| #2 | African Regional Industrial Property Organization | 1 | |
| #3 | Australia | 1 | |
| #4 | Denmark | 1 | |
| #5 | United Kingdom | 1 | |
| #6 | Ireland | 1 | |
| #7 | Portugal | 1 | |
| #8 | WIPO (World Intellectual Property Organization) | 1 | |
| #9 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Measurement | |
| #2 | Biotechnology | |
| #3 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Analysing materials | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Knox Peter | 6 |
| #2 | Bishop David H L | 3 |
| #3 | Roy Polly | 3 |
| #4 | David H L Bishop | 1 |
| #5 | Polly Roy | 1 |
| Publication | Filing date | Title |
|---|---|---|
| GB8919102D0 | A recombinant adenovirus dna sequence,a recombinant adenovirus expressing the dna sequence and a rhabdovirus vaccine including the recombinant adenovirus | |
| IE883604L | Method of estimating systemic cholesterol from capillary¹blood | |
| AP8800083A0 | Production of bluetongue virus antigens using a baculovirus expression vector. | |
| ZA8800849B | Production of bluetongue virus antigens using a baculovirus expression vector |